EGF and breast cancer: The upregulation of EGF, a key growth factor in this pathway, suggests that PCBs may promote tumor growth and progression by enhancing EGF receptor signaling, a mechanism previously linked to poor prognosis in breast cancer (Balanis and Carlin, 2017; Garcia et al., 2006).